CID-4785700

• CAT Number: I012722
• CAS Number: 852935-07-0
• Molecular Formula: C22H23ClFN3O3
• Molecular Weight: 431.89
• Purity: ≥95%
• Synonyms: Rtt109-IN-I; N-[(2-Chloro-6-fluorophenyl)methyl]-2-(2,5-dioxo-4-phenyl-4-propylimidazolidin-1-yl)-N-methylacetamide
• IUPAC Name: N-[(2-chloro-6-fluorophenyl)methyl]-2-(2,5-dioxo-4-phenyl-4-propylimidazolidin-1-yl)-N-methylacetamide
• InChI: InChI=1S/C22H23ClFN3O3/c1-3-12-22(15-8-5-4-6-9-15)20(29)27(21(30)25-22)14-19(28)26(2)13-16-17(23)10-7-11-18(16)24/h4-11H,3,12-14H2,1-2H3,(H,25,30)
• InChIKey: LYOOCPLGHJKLEG-UHFFFAOYSA-N
• SMILES: CCCC1(C(=O)N(C(=O)N1)CC(=O)N(C)CC2=C(C=CC=C2Cl)F)C3=CC=CC=C3

CID-4785700(CAT: I012722) is a novel and specific inhibitor of Rtt109, a histone acetyltransferase (HAT) critical for histone H3 acetylation and chromatin regulation. By targeting Rtt109 activity, it disrupts histone modification processes essential for DNA replication and repair, making it particularly valuable in epigenetics research. This compound enables the study of Rtt109’s role in chromatin dynamics, transcriptional regulation, and genome stability. CID-4785700 is a powerful tool for advancing research into histone acetylation mechanisms and developing therapeutic strategies targeting epigenetic dysregulation in cancer and other diseases.